Logo

Abbott Launches Afinion HbA1c Dx (Rapid Point-Of-Care Test) to Aid the Diagnosis of Diabetes

Share this

Abbott Launches Afinion HbA1c Dx (Rapid Point-Of-Care Test) to Aid the Diagnosis of Diabetes

Shots:

  • Abbott’s Afinion HbA1c Dx assay is a rapid point-of-care test- available for use on the Afinion 2 Analyzer & Afinion AS100 Analyzer to aid health care professionals in the diagnosis of diabetes
  • The test is designed to determine glycated hemoglobin (HbA1c) level in blood in three minutes- allowing clinicians to diagnose patients and formulating individualized care plans during patient consultation and has received FDA clearance for use on the Afinion AS100 Analyzer in May’18
  • The Afinion 2 Analyzer is a platform- simplifying the delivery of actionable- accurate measurements of HbA1c and ACR (albumin-to-creatinine ratio) results at the point of care- offering clinicians to make fast & accurate medical decisions

Ref: Abbott | Image:  Abbott

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions